FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy

Specialty drugmakers lobbying together

Tools

Here's a quandary: You're a good-sized drugmaker, but not a behemoth able to throw your weight around the industry's big trade associations. So how do you get your voice heard in our nation's capital? Form your own association, of course. That's exactly what Celgene, Cephalon, Cubist, Endo, Millennium, Purdue and Sepracor are doing: Banding together under the name America's Specialty Medicines Companies, and hiring a D.C. law firm for help getting organized.

What might this assortment's key issues be? That's unclear as yet. But you can bet we'll hear more from them as time goes by.

- read the item at In Vivo

Related Articles:
Dems swayed by pharma lobbying push
PhRMA plows $22M into 2007 lobbying
Millennium spent $1.3M on lobbying
Pharma lobbies big-time in '07

More stories about Endo   Cubist   Cephalon   Celgene   Trade Associations   Sepracor   Purdue   Millennium   Lobbyists  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 22 + 78?
To combat spam, please solve the math question above.